The selective NOX4 inhibitor GLX7013159 decreases blood glucose concentrations and human beta-cell apoptotic rates in diabetic NMRI nu/nu mice transplanted with human islets

References

• Elksnis A, Martinell M, Eriksson O, et al. Heterogeneity of metabolic defects in type 2 diabetes and its relation to reactive oxygen species and alterations in beta-cell mass. Front Physiol. 2019;10:107. doi: 10.3389/fphys.2019.00107.
   PubMed Web of Science ®Google Scholar
• Chen K, Craige SE, Keaney JF. Jr. Downstream targets and intracellular compartmentalization in nox signaling. Antioxid Redox Signal. 2009;11(10):2467–2480. doi: 10.1089/ars.2009.2594.
   PubMed Web of Science ®Google Scholar
• Veith C, Boots AW, Idris M, et al. Redox imbalance in idiopathic pulmonary fibrosis: a role for oxidant cross-talk between NADPH oxidase enzymes and mitochondria. Antioxid Redox Signal. 2019;31(14):1092–1115. doi: 10.1089/ars.2019.7742.
   PubMed Web of Science ®Google Scholar
• Guichard C, Moreau R, Pessayre D, et al. NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes? Biochem Soc Trans. 2008;36(Pt 5):920–929. doi: 10.1042/BST0360920.
   PubMedGoogle Scholar
• Sedeek M, Callera G, Montezano A, et al. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. Am J Physiol Renal Physiol. 2010;299(6):F1348–F1358. doi: 10.1152/ajprenal.00028.2010.
   PubMed Web of Science ®Google Scholar
• Chen F, Haigh S, Barman S, et al. From form to function: the role of Nox4 in the cardiovascular system. Front Physiol. 2012;3:412. doi: 10.3389/fphys.2012.00412.
   PubMed Web of Science ®Google Scholar
• Nisimoto Y, Diebold BA, Cosentino-Gomes D, et al. Nox4: a hydrogen peroxide-generating oxygen sensor. Biochemistry. 2014;53(31):5111–5120.
   PubMed Web of Science ®Google Scholar
• Clempus RE, Sorescu D, Dikalova AE, et al. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. ATVB. 2007;27(1):42–48. doi: 10.1161/01.ATV.0000251500.94478.18.
   Google Scholar
• Schröder K, Wandzioch K, Helmcke I, et al. Nox4 acts as a switch between differentiation and proliferation in preadipocytes. ATVB. 2009;29(2):239–245. doi: 10.1161/ATVBAHA.108.174219.
   Google Scholar
• Goettsch C, Babelova A, Trummer O, et al. NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis. J Clin Invest. 2013;123(11):4731–4738. doi: 10.1172/JCI67603.
   PubMed Web of Science ®Google Scholar
• Cheng G, Cao Z, Xu X, et al. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene. 2001;269(1-2):131–140. doi: 10.1016/S0378-1119(01)00449-8.
   PubMed Web of Science ®Google Scholar
• Serrander L, Cartier L, Bedard K, et al. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J. 2007;406(1):105–114. doi: 10.1042/BJ20061903.
   PubMedGoogle Scholar
• Shanmugasundaram K, Nayak BK, Friedrichs WE, et al. NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance. Nat Commun. 2017;8(1):1–15. doi: 10.1038/s41467-017-01106-1.
   PubMedGoogle Scholar
• Guo S, Chen X. The human Nox4: gene, structure, physiological function and pathological significance. J Drug Target. 2015;23(10):888–896. doi: 10.3109/1061186X.2015.1036276.
   PubMed Web of Science ®Google Scholar
• Bernard K, Logsdon NJ, Miguel V, et al. NADPH oxidase 4 (Nox4) suppresses mitochondrial biogenesis and bioenergetics in lung fibroblasts via a nuclear factor erythroid-derived 2-like 2 (Nrf2)-dependent pathway. J Biol Chem. 2017;292(7):3029–3038. doi: 10.1074/jbc.M116.752261.
   PubMed Web of Science ®Google Scholar
• Gerber PA, Rutter GA. The role of oxidative stress and hypoxia in pancreatic beta-cell dysfunction in diabetes mellitus. Antioxid Redox Signal. 2017;26(10):501–518. doi: 10.1089/ars.2016.6755.
   PubMed Web of Science ®Google Scholar
• Fred RG, Kappe C, Ameur A, et al. Role of the AMP kinase in cytokine-induced human EndoC-betaH1 cell death. Mol Cell Endocrinol. 2015;414:53–63. doi: 10.1016/j.mce.2015.07.015.
   PubMed Web of Science ®Google Scholar
• Carlsson C, Borg LA, Welsh N. Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro. Endocrinology. 1999;140(8):3422–3428. doi: 10.1210/endo.140.8.6908.
   PubMed Web of Science ®Google Scholar
• Pecchillo Cimmino T, Ammendola R, Cattaneo F, et al. NOX dependent ROS generation and cell metabolism. Int J Mol Sci. 2023;24(3):2086. doi: 10.3390/ijms24032086.
   PubMed Web of Science ®Google Scholar
• Knock GA. NADPH oxidase in the vasculature: expression, regulation and signalling pathways; role in normal cardiovascular physiology and its dysregulation in hypertension. Free Radic Biol Med. 2019;145:385–427. doi: 10.1016/j.freeradbiomed.2019.09.029.
   PubMed Web of Science ®Google Scholar
• Matsushima S, Sadoshima J. Yin and yang of NADPH oxidases in myocardial Ischemia-Reperfusion. Antioxidants (Basel). 2022;11(6):1069. doi: 10.3390/antiox11061069.
   PubMedGoogle Scholar
• Boonpraman N, Yoon S, Kim CY, et al. NOX4 as a critical effector mediating neuroinflammatory cytokines, myeloperoxidase and osteopontin, specifically in astrocytes in the hippocampus in Parkinson’s disease. Redox Biol. 2023;62:102698. Jundoi: 10.1016/j.redox.2023.102698.
   PubMed Web of Science ®Google Scholar
• Thannickal VJ, Jandeleit-Dahm K, Szyndralewiez C, et al. Pre-clinical evidence of a dual NADPH oxidase 1/4 inhibitor (setanaxib) in liver, kidney and lung fibrosis. J Cell Mol Med. 2023;27(4):471–481. doi: 10.1111/jcmm.17649.
   PubMed Web of Science ®Google Scholar
• Brown OI, Bridge KI, Kearney MT. Nicotinamide adenine dinucleotide phosphate oxidases in glucose homeostasis and diabetes-related endothelial cell dysfunction. Cells. 2021;10(9):2315. doi: 10.3390/cells10092315.
   PubMed Web of Science ®Google Scholar
• Syed I, Kyathanahalli CN, Jayaram B, et al. Increased phagocyte-like NADPH oxidase and ROS generation in type 2 diabetic ZDF rat and human islets: role of Rac1-JNK1/2 signaling pathway in mitochondrial dysregulation in the diabetic islet. Diabetes. 2011;60(11):2843–2852. doi: 10.2337/db11-0809.
   PubMed Web of Science ®Google Scholar
• Eguchi N, Vaziri ND, Dafoe DC, et al. The role of oxidative stress in pancreatic β cell dysfunction in diabetes. IJMS. 2021;22(4):1509. doi: 10.3390/ijms22041509.
   Google Scholar
• Block K, Gorin Y, Abboud HE. Subcellular localization of Nox4 and regulation in diabetes. Proc Natl Acad Sci US A. 2009;106(34):14385–14390.
   PubMed Web of Science ®Google Scholar
• Wang X, Elksnis A, Wikström P, et al. The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro. PLoS One. 2018;13(9):e0204271. doi: 10.1371/journal.pone.0204271.
   Web of Science ®Google Scholar
• Anvari E, Wikstrom P, Walum E, et al. The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice. Free Radic Res. 2015;49(11):1308–1318. doi: 10.3109/10715762.2015.1067697.
   PubMed Web of Science ®Google Scholar
• Elksnis A, Cen J, Wikström P, et al. Pharmacological inhibition of NOX4 improves mitochondrial function and survival in human beta-cells. Biomedicines. 2021;9(12):1865. doi: 10.3390/biomedicines9121865.
   PubMed Web of Science ®Google Scholar
• Jaquet V, Marcoux J, Forest E, et al. NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action. Br J Pharmacol. 2011;164(2b):507–520. doi: 10.1111/j.1476-5381.2011.01439.x.
   PubMed Web of Science ®Google Scholar
• Hirano K, Chen WS, Chueng AL, et al. Discovery of GSK2795039, a novel small molecule NADPH oxidase 2 inhibitor. Antioxid Redox Signal. 2015;23(5):358–374. doi: 10.1089/ars.2014.6202.
   PubMed Web of Science ®Google Scholar
• Xiong Q, Kadota S, Tani T, et al. Antioxidative effects of phenylethanoids from cistanche deserticola. Biol Pharm Bull. 1996;19(12):1580–1585. doi: 10.1248/bpb.19.1580.
   PubMed Web of Science ®Google Scholar
• Lopez-Talavera JC, Garcia-Ocaña A, Sipula I, et al. Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation. Endocrinology. 2004;145(2):467–474. doi: 10.1210/en.2003-1070.
   PubMed Web of Science ®Google Scholar
• Bunnag SC, Warner NE, Bunnag S. Effect of alloxan on the mouse pancreas during and after recovery from diabetes. Diabetes. 1967;16(2):83–89. doi: 10.2337/diab.16.2.83.
   PubMed Web of Science ®Google Scholar
• Ighodaro OM, Adeosun AM, Akinloye OA. Alloxan-induced diabetes, a common model for evaluating the glycemic-control potential of therapeutic compounds and plants extracts in experimental studies. Medicina (Kaunas, Lithuania). 2017;53(6):365–374.
   PubMed Web of Science ®Google Scholar
• King A, Lau J, Nordin A, et al. The effect of capsule composition in the reversal of hyperglycemia in diabetic mice transplanted with microencapsulated allogeneic islets. Diabetes Technol Therap. 2003;5(4):653–663. doi: 10.1089/152091503322250677.
   PubMedGoogle Scholar
• Marrif HI, Al-Sunousi SI. Pancreatic β cell mass death. Front Pharmacol. 2016;7:83. doi: 10.3389/fphar.2016.00083.
   PubMed Web of Science ®Google Scholar
• Tomita T. Immunocytochemical localisation of caspase-3 in pancreatic islets from type 2 diabetic subjects. Pathology. 2010;42(5):432–437. doi: 10.3109/00313025.2010.493863.
   PubMed Web of Science ®Google Scholar
• Plecitá-Hlavatá L, Jabůrek M, Holendová B, et al. Glucose-Stimulated insulin secretion fundamentally requires H 2 O 2 signaling by NADPH oxidase 4. Diabetes. 2020;69(7):1341–1354. doi: 10.2337/db19-1130.
   PubMed Web of Science ®Google Scholar
• Xirouchaki CE, Jia Y, McGrath MJ, et al. Skeletal muscle NOX4 is required for adaptive responses that prevent insulin resistance. Sci Adv. 2021;7(51):eabl4988. doi: 10.1126/sciadv.abl4988.
   Web of Science ®Google Scholar
• Nowotny K, Jung T, Hohn A, et al. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules. 2015;5(1):194–222. doi: 10.3390/biom5010194.
   PubMed Web of Science ®Google Scholar
• Yang Q, Wu FR, Wang JN, et al. Nox4 in renal diseases: an update. Free Radical Biology & Medicine. 2018;124:466–472.
   PubMed Web of Science ®Google Scholar
• Schröder K, Zhang M, Benkhoff S, et al. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res. 2012;110(9):1217–1225. doi: 10.1161/CIRCRESAHA.112.267054.
   PubMed Web of Science ®Google Scholar
• Zhang M, Brewer AC, Schröder K, et al. NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci USA. 2010;107(42):18121–18126.
   PubMed Web of Science ®Google Scholar
• Kuroda J, Ago T, Matsushima S, et al. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci USA. 2010;107(35):15565–15570.
   PubMed Web of Science ®Google Scholar
• Radermacher KA, Wingler K, Langhauser F, et al. Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress. Antioxid Redox Signal. 2013;18(12):1418–1427. doi: 10.1089/ars.2012.4797.
   PubMed Web of Science ®Google Scholar
• Bachmanov AA, Reed DR, Beauchamp GK, et al. Food intake, water intake, and drinking spout side preference of 28 mouse strains. Behav Genet. 2002;32(6):435–443.
   PubMed Web of Science ®Google Scholar